Mechanism of Action
Vitamin C is an electron donor. This simple property explains all of its biological functions. It donates one or two electrons to reactive oxygen species (unstable molecules naturally produced by metabolism), neutralizing them before they damage membrane lipids, proteins or DNA.
Beyond this direct antioxidant action, vitamin C serves as a cofactor for a family of enzymes called iron-dependent dioxygenases. These enzymes catalyze hydroxylation reactions essential for collagen synthesis, carnitine production (a molecule that transports fatty acids to mitochondria for energy production) and the biosynthesis of certain neurotransmitters. Vitamin C keeps iron at the active center of these enzymes in its reduced form, a necessary condition for their function.
In the intestinal tract, this same reducing power converts non-heme dietary iron from its ferric form into its absorbable form. Iron bioavailability increases significantly. Vitamin C also regenerates oxidized vitamin E in cell membranes, recreating an antioxidant network where each molecule supports the other.
Key Benefits
- Strong
Vitamin C contributes to the normal function of the immune system. A Cochrane meta-analysis of 29 controlled trials involving over 11,000 participants shows that regular supplementation reduces the duration of cold episodes by 8% in adults.
- Strong
Vitamin C contributes to the protection of cells from oxidative stress. Its electron donor role neutralizes reactive oxygen species, a mechanism confirmed by multiple trials measuring plasma oxidative damage markers.
- Strong
Vitamin C contributes to normal collagen formation for the normal function of skin. Controlled trials show that oral supplementation improves skin hydration and dermal density in women over 40.
- Strong
Vitamin C increases iron absorption. Pharmacological data demonstrate it doubles to triples non-heme iron bioavailability when consumed at the same meal.
- Strong
Vitamin C contributes to the regeneration of the reduced form of vitamin E. This antioxidant recycling maintains the protection of cell membranes against lipid peroxidation.
- Moderate
Vitamin C contributes to the reduction of tiredness and fatigue. A double-blind controlled trial in office workers observed a significant reduction in perceived fatigue after two weeks of supplementation at 500 mg per day.
- Moderate
Large cohort epidemiological data (EPIC-Norfolk, over 20,000 participants followed for 10 years) associate higher plasma vitamin C concentrations with reduced risk of cerebrovascular events.
Dosage & Forms
L-ascorbic acid remains the reference form, the most studied and the most bioavailable at dietary and moderate doses. Beyond 200 mg per dose, pharmacokinetics become non-linear. Intestinal absorption plateaus between 70 and 90%, dropping below 50% above 1,000 mg. Buffered forms (sodium ascorbate, calcium ascorbate) offer better gastric tolerance but no demonstrated absorption advantage. Liposomal vitamin C partially bypasses saturation of the intestinal SVCT1 transporter, but comparative data remain limited.
Singular selected ethylcellulose-coated L-ascorbic acid. This food-grade coating protects the molecule from oxidation and moisture, two major degradation factors in a powder environment. It ensures gradual release in the digestive tract, extending the absorption window and reducing transient plasma peaks that promote renal excretion. The base dose is calibrated at 500 mg, adjustable from 250 mg to 1,000 mg based on individual biological profile.
In the Singular Formula
Inclusion rationale
Vitamin C contributes to the normal formation of collagen for the normal function of skin and blood vessels, to the protection of cells against oxidative stress, to the normal functioning of the immune system and increases iron absorption. Humans are one of the few mammals unable to synthesize vitamin C, a genetic peculiarity resulting from the mutation of the GULO gene approximately 60 million years ago. Vitamin C is an indispensable cofactor of prolyl hydroxylases and lysyl hydroxylases, the enzymes that catalyze the hydroxylation of proline and lysine in collagen. Without these modifications, the collagen triple helix cannot form correctly. In the formula, vitamin C works in concert with type I collagen, glycine and L-lysine to support complete collagen synthesis. It also facilitates non-heme iron absorption by keeping it in reduced form (Fe2+) in the intestinal tract, a direct synergy with the iron bisglycinate present in the formula. Vitamin C also participates in the regeneration of oxidized vitamin E and in the biosynthesis of carnitine and noradrenaline.
Selected form
L-ascorbic acid coated with ethylcellulose, an inert food-grade polymer. This coating protects vitamin C from oxidation and moisture degradation, two major weaknesses of unprotected ascorbic acid. Ethylcellulose enables gradual release in the digestive tract, extending the intestinal absorption window. The human body does not synthesise vitamin C (unlike most mammals). It contributes to normal immune system function and to the protection of cells from oxidative stress. Quality: non-GMO.
Formula dosage
0 to 1,000 mg.
Synergies in the formula
Safety & Precautions
Vitamin C has a favorable safety profile at nutritional and moderately supranutritional doses. The European Food Safety Authority does not set a tolerable upper intake level for vitamin C in adults, given its low toxicity. The commonly accepted tolerance threshold is 2,000 mg per day.
Above 1,000 mg per day, digestive disturbances (osmotic diarrhea, abdominal cramps) may occur in some individuals. People at risk of iron overload (hemochromatosis) should exercise caution, as vitamin C increases intestinal iron absorption. Supplementation is not recommended for individuals with a history of oxalate kidney stones, since vitamin C is an oxalate precursor.
No major interactions with common medications are documented. Vitamin C may interfere with certain biological assays (capillary blood glucose, urinary dipsticks). Pregnant or breastfeeding women can consume vitamin C at recommended nutritional doses.
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Hemilä H, Chalker E | 2013 | Meta-analysis | Cochrane Database of Systematic Reviews | View on PubMed |
Vitamin C for preventing and treating the common cold Meta-analysis of 29 controlled trials involving over 11,000 participants. Regular supplementation reduces cold duration by 8% in adults and 14% in children, with no significant effect on incidence in the general population. | ||||
| Carr AC, Maggini S | 2017 | Systematic Review | Nutrients | View on PubMed |
Vitamin C and Immune Function Systematic review of mechanisms by which vitamin C supports innate and adaptive immune defenses. Concludes that a daily intake of 100 to 200 mg optimizes cellular and plasma concentrations. | ||||
| Pullar JM, Carr AC, Vissers MCM | 2017 | Systematic Review | Nutrients | View on PubMed |
The Roles of Vitamin C in Skin Health Review of clinical evidence on oral and topical vitamin C in skin health. Oral supplementation improves hydration and reduces wrinkle formation, linked to its cofactor role in collagen synthesis. | ||||
| Padayatty SJ et al. | 2004 | Randomised Controlled Trial | Annals of Internal Medicine | View on PubMed |
Vitamin C pharmacokinetics: implications for oral and intravenous use Reference pharmacokinetic study demonstrating the non-linearity of oral absorption. Intestinal absorption plateaus at approximately 200 mg per dose, with increasing renal excretion beyond that threshold. | ||||
| Myint PK et al. | 2008 | Cohort Study | American Journal of Clinical Nutrition | View on PubMed |
Plasma vitamin C concentrations predict risk of incident stroke over 10 y in 20 649 participants of the European Prospective Investigation into Cancer Norfolk prospective population study Prospective cohort of over 20,000 participants followed for 10 years. Higher plasma vitamin C concentrations are significantly associated with reduced stroke risk. | ||||